Edwards lands four-year $500 million revolving credit facility | Funding Roundup

August 9, 2011 By MassDevice staff

Edwards Lifesciences Corp. (NYSE:EW) landed a new four-year $500 million credit facility after canceling a prior one a couple months early.

The old facility was a five-year deal, also for $500 million, that was scheduled to mature September 29, 2011.

Under the new agreement, Edwards, which ranked 46th on the MassDevice Big 100 list of the world’s largest medical device companies, is eligible to increase its facility up to another $250 million, subject to certain terms and conditions.

Here’s a roundup of other dealflow and investment news:

Knome raises $5 million for gene sequencing
Cambridge, Mass.-based Knome Inc. raised $5 million of a $20 million equity funding round that began mid-July. The $5 million came from one unnamed investor, filings show.
Read more

Cardia touts closes $2 million round
Minnesota-based Cardia Inc., maker of cardiac implants for treatment of congenital heart defects, closed a $2 million funding round spread across 24 investors.
Read more

NeoChord pulls in nearly half of a $11 million round
Minnesota-based biotech firm NeoChord Inc. raised just over $5 million of a $11 million series B preferred stock and warrant round, gathered from 44 investors. NeoChord makes a minimally invasive implant for patients with ruptured or elongated mitral valves.
Read more

Restoration Robotics touts $41 million for hair restoration
Restoration Robotics Inc. landed $41 million through a series C financing round. Investment in the physician-controlled, computer-aided hair restoration robotics company was led by Clarus Ventures, and joined by Sutter Hill Ventures, Alloy Ventures and Interwest Partners.
Read more

Vessix Vascular closes a $23 million round
Laguna Hills, Calif.-based radiofrequency catheter maker Vessix Vascular Inc. closed a $23 million series B preferred stock financing round led by Edmond de Rothschild Investment Partners. The company plans to use the funds as working capital to accelerate development initiatives and to fund clinical trials to expand clinical indications for its RF balloon catheter technology.
Read more

Abaxis repurchases stock
Abaxis Inc.’s (NSDQ:ABAX) board of directors approved a $40 million common stock repurchase program, to be made from time to time on the open market.
Read more

Acutus Medical wins $1 million from private investors
San Diego, Calif.-based Acutus Medical Inc. landed a $1 million investment from private investors, including Index Ventures. The company develops electrophysiological mapping technology for treatment of cardiac arrhythmias.
Read more

Steris wins second EUA to decontaminate up to 30m respirators per day
Steris (NYSE:STE) has won an FDA emergency use authorization (EUA) for a new steam sterilization method to decontaminate used N95 respirators. The EUA covers the new Steris Steam Decon cycle to decontaminate 3M 1860, 3M 1860S, and 3M 1804 NIOSH-approved N95 respirators that are or might be contaminated with SARS-CoV-2 and other pathogenic microorganisms. The FDA… […]
Raumedic supplies adhesive for production of thousands of ventilators
When the federal government tapped Hamilton Medical to produce tens of thousands of ventilators for COVID-19 patients, the company turned to its long-term partner Raumedic for a special silicone adhesive. The adhesive is solvent- and plasticizer-free, easy to use and bonds silicones to each other and to other materials, such as metal or plastics, according… […]
FDA signals PPE shortage, issues EUA for more
The FDA has issued a call for manufacturers to produce more non-surgical gowns and other personal protective equipment (PPE) as the coronavirus pandemic makes its way across the country. The emergency use authorization issued Friday also listed conductive shoes and shoe covers, operating room shoes and shoe covers, surgical helmets and caps and other surgical accessories. The… […]
Ga. warehouse workers sue Sterigenics, ConMed over EtO exposure
Fifty-three people who worked in an Atlanta-area warehouse that stored medical devices sterilized by ethylene oxide (EtO) filed suit this week against Sterigenics and its parent company over exposure to the gas. The plaintiffs or their families claim that long-term EtO exposure to the sterilized devices, which they unloaded, handled, warehoused and distributed, caused multiple… […]
FDA eases regs on certain device changes during pandemic
The FDA will allow limited changes to certain devices so medtech companies can address manufacturing and supply chain issues due to COVID-19-related disruptions. In a guidance released yesterday, the agency said it would allow changes to devices approved through its premarket approval (PMA) and humanitarian device exemption (HDE) pathways as long as those changes do… […]
15 heart devices that could boost their manufacturers’ sales
Before the coronavirus pandemic hit, medtech companies large and small were making notable news with a number of innovative heart devices. Some of these same companies took a big hit to their bottom lines when the danger of spreading COVID-19 and using up precious personal protective equipment convinced hospitals to limit non-urgent procedures. Now hospitals… […]
This wearable could help people practice safe distancing amid COVID-19
Imec spinoff Lopos, with the Ghent University (Belgium) announced the Lopos SafeDistance wearable for promoting safety during the COVID-19 pandemic. As businesses attempt to return to in-person activities, the collaboration designed the wearable device to warn employees through an audible or haptic alarm when they are violating social distancing guidelines as they approach each other.… […]
FDA launches COVID-19 research initiative
The FDA has entered an agreement with healthcare analytics company Aetion to research urgent questions about COVID-19. The New York City-based company said the research will support FDA objectives to explore the natural history of the disease, as well as treatment and diagnostic patterns using relevant, novel data sources and analyzing these data according to well-established principles.… […]
Medtronic execs see quick recovery, increased M&A
If Medtronic’s troubling Q4 report offers a snapshot of a company hit hard by COVID-19, the next image in the sequence may show a faster-than-expected recovery and increased merger-and-acquisition of smaller companies. In the quarterly call on Thursday morning, Medtronic CEO Geoff Martha and CFO Karen Parkhill expressed optimism that the company’s businesses already are showing signs… […]
Webinar: How COVID-19 is changing medical device regulation, clinical trials and reimbursement
Tuesday, June 23, 2020 11:30 a.m. eastern time / 8:30 a.m. pacific time As the life sciences industry works to contain the COVID-19 outbreak, it is clear that the dynamics of the medical device and digital health industries are being disrupted. Going virtual is the new normal and executives of medtech and healthtech… […]
IMDRF recommends UL 2900 compliance for medical device cybersecurity
By Stewart Eisenhart, Emergo Group Recent guidance published by the International Medical Devices Regulators Forum (IMDRF) that covers medical device cybersecurity best practices includes recommendations that manufacturers comply with the UL 2900 set of standards for network-connectable devices. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post… […]